Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?

Journal of Geriatric Cardiology

Volumn 8, Issue 4, 2011, Pages 260-262

  Guo, Yong Fang ^a   An, Yi ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Beta blockers; Chronic heart failure; Heart rate

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

DRUG EFFICACY; DRUG TARGETING; HEART ATRIUM PACING; HEART FAILURE; HEART FUNCTION; HEART RATE; HUMAN; LETTER; LOW DRUG DOSE; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; RECOMMENDED DRUG DOSE;

EID: 84855395633     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1263.2011.00260     Document Type: Letter

References (21)

1. Hunt SA; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005; 46: E1-E82.
2. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial. Lancet 2003; 362: 7-13. (Pubitemid 36835815)
3. Lechat P, Packer M, Chalon S, et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double blind, placebo controlled, randomized trials. Circulation 1998; 98: 1184-1191. (Pubitemid 28436168)
4. Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001; 3: 351-357. (Pubitemid 32895844)
5. Liggett SB, Mialet-Perez J, Thaneemit-Chen S, et al. A polymorphism within a conserved beta (1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure. Proc Natl Acad Sci USA 2006; 103: 11288-11293. (Pubitemid 44156511)
6. Palakodeti V, Oh S, Oh BH, et al. Force-frequency effect is a powerful determinant of myocardial contractility in the mouse. Am J Physiol Heart Circ Physiol 1997; 273: H1283-H1290.
7. Hasenfuss G, Holubarsch H, Hermann P, et al. Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994; 15: 164-170. (Pubitemid 24110691)
8. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 1988; 85: 242-244.
9. Fosbøl EL, Seibæk M, Brendorp B, et al. Long-term prognostic importance of resting heart rate in patients with left ventricular dysfunction in connection with either heart failure or myocardial infarction: The DIAMOND study. Int J Cardiol 2010; 140: 279-286.
10. Lechat P, Hulot JS. Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103: 1428-1433. (Pubitemid 32220636)
11. MERIT-HF study group: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
12. Lechat P, Escolano S, Golmard JL, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation 1997; 96: 2197-2205. (Pubitemid 27425823)
13. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001; 103: 1428-1433. (Pubitemid 32220636)
14. Metra M, Torp-Pedersen C, Swedberg K, et al. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 2005; 26: 2259-2268. (Pubitemid 41541389)
15. Mulder P, Barbier S, Chagraoui A, et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004; 109: 1674-1679. (Pubitemid 38451726)
16. Nagatsu M, Spinale FG, Koide M, et al. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. Circulation 2000; 101: 653-659. (Pubitemid 30094737)
17. Yamakawa H, Takeuchi M, Takaoka H, et al. Negative chronotropic effect of β-blockade therapy reduces myocardial oxygen expenditure for nonmechanical work. Circulation 1996; 4: 340-345. (Pubitemid 26266117)
18. Thackray SD, Ghosh JM, Wright GA, et al. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. Am Heart J 2006; 152: 713. E9-E13.
19. Johnson JA, Zineh I, Puckett BJ, et al. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 2003; 74: 44-52. (Pubitemid 36776175)
20. Wikstrand J, Hjalmarson A, Waagstein F, et al. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol 2002; 40: 491-498.
21. Flannery G, Gehrig-Mills R, Billah B, et al. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving Beta-blockers. Am J Cardiol 2008; 101: 865-869.